Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00162591|
Recruitment Status : Unknown
Verified October 2004 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was: Recruiting
First Posted : September 13, 2005
Last Update Posted : November 22, 2005
|Condition or disease||Intervention/treatment||Phase|
|Pain||Drug: remifentanyl||Not Applicable|
Pain is difficult to estimate in ICU because most of the patients are sedated. Bispectral index could be helpful in detecting this pain in ICU patients. Remifentanil is a morphinomimetic product with short half life that could be interesting for short nociceptive stimuli, as bronchoalveolar lavage.
The purpose of this study is to evaluate the impact of remifentanil infusion on bispectral index (BIS) variations during bronchoalveolar lavage.
It is a prospective, double blind study, versus placebo on 40 sedated and critically ill patients.
The hypothesis is that BIS can study analgesia in sedated patient.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl|
|Study Start Date :||October 2004|
- BIS variation during bronchoalveolar lavage
- Systolic blood pressure, diastolic blood pressure, heart rate viation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00162591
|Contact: QUINTARD h Hervé, MDfirstname.lastname@example.org|
|Surgical ICU Bichat Claude Bernard||Recruiting|
|Paris, France, 75018|
|Contact: QUINTARD H Hervé, MD +33140258116 email@example.com|
|Principal Investigator: QUINTARD H Hervé, MD|
|Principal Investigator:||QUINTARD H Hervé, MD||Surgical ICU Bichat Claude Bernard (Paris, France)|